Commentary on how medicinal cannabis can evolve in a similar manner as the pharmaceutical industry did.
In this study, six different brands of CBD oil pet supplements were obtained and untargeted analyses using gas phase-time of flight mass spectrometry were performed.
From 9/11 First Responder to Cancer Survivor and Cannabis Entrepreneur: How One Man’s Cannabis Journey Is Impacting the Medicinal Field
Aryn Sieber, the founder and CEO of CBD Essentials and Cannaisseur Brands as well as the founder of CannaCauses Foundation, discusses his experiences as a 9/11 first responder, his battle with stage IV cancer, and how cannabis impacted his life.
GW Pharmaceuticals recently announced the company’s financial results from the second quarter of 2019.
GW Pharmaceuticals plc (London, UK and Carlsbad, California) announced the financial results for the last quarter of 2018, which included two months of sales for Epidiolex.
Where does cannabidiol’s (CBD) legal status stand following the 2018 Farm Bill? One attorney looks at common misperceptions.
Compact mass spectrometry, in combination with suitable sample introduction techniques—such as the atmospheric solids analysis probe, thin-layer chromatography, and classical liquid chromatography techniques—can be used effectively for the detection and quantification of cannabinoids and pesticides in cannabis-related material and contraband.
QuEChERS is introduced to the discipline of forensic testing as a viable method for the extraction of pesticides and cannabinoids in various complex sample matrices
Rapid Determination of 24 Synthetic and Natural Cannabinoids for LC–MS-MS Screening in Natural Products and Drug Inspection Applications
Other techniques for monitoring cannabinoids, such as GC–MS and LC–MS, are limited to screening known species and are therefore always one step behind the designer drug market—where new, previously unknown variations of analogs of cannabinoids are constantly being synthesized. The method presented here addresses this problem by providing accurate masses for all detected species, thus allowing postanalysis identification of initially untargeted compounds.
An interview with Sue Sisley